Cita APA (7a ed.)
García-Alfonso, P., Saiz-Rodríguez, M., Mondéjar, R., Salazar, J., Páez, D., Borobia, A. M., . . . Abad-Santos, F. (2022). Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines. Current Treatment Options in Oncology, 23(2), 483-495.
Cita Chicago Style (17a ed.)
García-Alfonso, P., et al. "Consensus of Experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the Genotyping of DPYD in Cancer Patients Who Are Candidates for Treatment with Fluoropyrimidines." Current Treatment Options in Oncology 23, no. 2 (2022): 483-495.
Cita MLA (9a ed.)
García-Alfonso, P., et al. "Consensus of Experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the Genotyping of DPYD in Cancer Patients Who Are Candidates for Treatment with Fluoropyrimidines." Current Treatment Options in Oncology, vol. 23, no. 2, 2022, pp. 483-495.
Precaución: Estas citas no son 100% exactas.